Medisafe Covid-19 survey- Data sample
Provided By: Medisafe Inc.
Medisafe Covid-19 survey- Data sample
Provided By: Medisafe Inc.
Medisafe conducted a survey to global users during the beginning of the COVID-19 outbreak to assess the level of anticipated interruption with medication management routines and health management routines as a result of quarantine guidelines. This product includes three patients answers to a five questions survey, sent via the Medisafe App.
Product offers
The following offers are available for this product. Choose an offer to view the pricing and access duration options for the offer. Select an offer and continue to subscribe. Your subscription begins on the date that your request is approved by the provider. Additional taxes or fees might apply.
Public offer
Payment schedule: Upfront payment | Offer auto-renewal: Supported
$0 for 12 months
Overview
Product Overview:
Geographic coverage: Global
Data was collected during the second half of April 2020
Questions included in survey:
What Concerns Do You Have About Taking Your Medications During the Coronavirus Outbreak?
How has your treatment changed as a result of Coronavirus, if at all?
Are you familiar with any savings programs for your medications?
Can you share with us why you're not enrolled in a savings program for your medications?
Have you been exposed to the Coronavirus?
Survey also includes self reported information on age and gender
Dataset includes a list of active medications on patients' Medisafe pill cabinet.
Medisafe is the leader of digital therapeutic companions for medication management. Currently there are over six million users world-wide who have incorporated our holistic approach to medication management into their everyday lives. Medisafe has generated over 12 billion data points of de-identified data representing medication behaviors spanning diverse therapeutic areas. Medisafe’s data products are sourced from real-world behaviors while maintaining the highest degree of patient privacy and security protection. Our de-identified data sets combine age and gender demographics, self reported medication management and digital behavior patterns and is both HIPAA and GDPR compliant. The data products offered on AWS are exclusively for qualified research endeavors. If interested in purchasing any of our data products we invite you to submit your request to dataaws@medisafe.com.
Updated: August 4, 2020
Provided By
Fulfillment Method
AWS Data Exchange
Data sets (1)
You will receive access to the following data sets
Revision access rules
All historical revisions | All future revisions
Contains sensitive information
Name | Type | Data dictionary | AWS Region |
|---|---|---|---|
Medisafe Covid-19 survey - Data sample | Not included | US East (N. Virginia) |
Usage information
By subscribing to this product, you agree that your use of this product is subject to the provider's offer terms including pricing information and Data Subscription Agreement . Your use of AWS services remains subject to the AWS Customer Agreement or other agreement with AWS governing your use of such services.
Support information
Support contact email address
Support contact URL
Refund policy
Free sample file
General AWS Data Exchange support